- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05093114
Friends, Family & Food: Food Allergy App for Youth ( F3A-App ) (F3A-App)
Friends, Family and Food: Interactive Virtual Environments for Children With Food Allergies
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
The central goal of this project was to develop an interactive, game-based application (App) for school-aged children (aged 8-12) with food allergies (FA) that would increase knowledge, improve behavioral skills for disease management, and ultimately reduce risk of negative outcomes. An effective FA intervention for children should target content areas of food avoidance and reaction management, and across these areas facilitate knowledge acquisition, develop behavioral skills, and provide practice using these skills in social contexts. Our Friends, Family, and Food App (F3A-App), consists of four related parts: (a) an interactive, game-based application that is the core of the program, (b) the experiential scenarios in interactive environments (e.g., school cafeteria vignette) that target knowledge and behavioral skills practice in social contexts, (c) two engaging multi-level games to build skills in food avoidance (Label Learning: Like it or Lose it!) and symptom assessment (Reaction Action!), and (d) a multi-tiered reward system that uses token economy-based reinforcement to enhance motivation and engagement (SeaLife Spectacular). From a user perspective, the interactive, game-based application provides opportunities to practice behavioral skills (e.g. negotiating pressures to accept trigger foods, requesting assistance from adults, responding to teasing/bullying) in role-play situations with immediate feedback and reinforcement.
In this Phase II project, we proposed to produce a fully-developed version of the F3A-App, including added content and enhanced features, and evaluate the final product in a randomized clinical trial.
The specific aims of Phase II were:
- To refine the F3A-App based on the user feedback and data collected in Phase I.
- To develop and field test additional content, including two additional interactive environments (family gathering, school pot-luck); and to increase gaming complexity (i.e. more levels and options) in Label Learning: Like it or Lose it! and Reaction Action! We conducted a small open trial in which 40 children with FA, ages 8-12, used selected segments containing the newly developed content. Children used the application for 2 weeks on their home computer or tablet. Feedback about device preference and usage was used to determine our focus in the Evaluation Stage (Aim 3).
- To assess the efficacy of the F3A-App vs. Standard Care (brief office visit and educational handouts) in a randomized clinical trial with 100 children with FA, ages 8-12. We expected the F3A-App would improve children's FA knowledge and self-efficacy to manage FA (primary outcomes) and would increase parent-child communication regarding FA management relative to Standard Care (secondary outcome). Our crossover design also enabled us to evaluate combined effects of Standard Care and the F3A-App through typical treatment channels (e.g., is the greatest efficacy found after a physician refers family to use the App after an office visit?) This Phase II STTR targeted pediatric FA, a critical public health problem of increasing prevalence. Our approach was innovative by incorporating an emphasis on behavioral skills practice using a platform that is engaging, interactive, affordable, and has high potential for broad dissemination. We envision that the F3A-App will ultimately serve as a template for interactive, game-based applications for children with other chronic conditions requiring self-management, such as asthma, diabetes, and celiac disease.
This record describes only the Open Trial portion of this Phase II STTR project.
Studientyp
Einschreibung (Tatsächlich)
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- child must be 8 -12 years of age
- child must have an active diagnosis of food allergy (FA), specifically one or more of the four most common FAs that may cause anaphylaxis (peanut, tree nut, milk, and egg), confirmed by a physician within the past two years
- child and parent must speak and read English
- child must have access to a computer with internet access
- child must have access to a smartphone or tablet
Exclusion Criteria:
- Any chronic health condition requiring substantial dietary self-management (e.g., diabetes).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Feedback interviews
Zeitfenster: Session 2, about 5 weeks after Session 1 and post-intervention
|
A semi-structured interview assessing child participants' opinions and feedback regarding game segments.
|
Session 2, about 5 weeks after Session 1 and post-intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Food Allergy Knowledge Questionnaire
Zeitfenster: Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Child report
|
Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Food Allergy Management Efficacy
Zeitfenster: Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Child report
|
Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Food Allergy Independent Measure
Zeitfenster: Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Parent/Caregiver report
|
Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Food Allergy Caregiver-Child Communication
Zeitfenster: Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Parent/Caregiver report
|
Baseline (pre-intervention/control condition), and Follow up (post-intervention/control condition; approximately 5 week after baseline)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Studienstuhl: Kathy Mann-Koepke, PhD, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- R42 HD075524 (Open Trial)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Nahrungsmittelallergie bei Kindern
-
Jazz PharmaceuticalsAbgeschlossenFood-EffektVereinigtes Königreich
-
Hutchison Medipharma LimitedAbgeschlossenFood-Effekt | GesundheitsthemenChina
-
Verastem, Inc.Abgeschlossen
-
Yale-NUS CollegeUnbekanntFood-Fotografie | Non-Food Photography | No Phone UseSingapur
-
Yale-NUS CollegeUnbekanntFood-Fotografie | Non-Food Photography | No Phone UseSingapur
-
Pennington Biomedical Research CenterAktiv, nicht rekrutierendNahrungsaufnahme | Energieaufnahme | Ernährungsbewertung | Food-FotografieVereinigte Staaten
-
Balance TherapeuticsAbgeschlossenGesund | Food-EffektVereinigtes Königreich
-
Astellas Pharma Global Development, Inc.AbgeschlossenGesunde Freiwillige | Pharmakokinetik von ASP015K | Food-EffektVereinigte Staaten
-
Astellas Pharma China, Inc.AbgeschlossenPharmakokinetik von Mirabegron | Food-Effekt | Gesunde chinesische ProbandenChina
-
Donesta BioscienceAbgeschlossen